Page last updated: 2024-08-24

capecitabine and Allergy, Drug

capecitabine has been researched along with Allergy, Drug in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (25.00)29.6817
2010's6 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ando, Y; Hayashi, T; Ikeda, Y; Ito, K; Kawada, K; Kumazawa, S; Maeda, K; Matsuoka, H; Murai, S; Ohta, H; Shiouchi, H; Yamada, S; Yasuda, K1
Akagi, Y; Fujino, S; Fujita, F; Katagiri, M; Kinugasa, T; Koushi, K; Miwa, K; Nagasu, S; Shimomura, S; Tajiri, K; Yomoda, T1
Aisu, N; Fujita, H; Hirata, K; Hoshino, S; Iwamoto, S; Kiyomi, F; Kosaka, T; Kotaka, M; Maeda, K; Matsuoka, H; Yamashita, Y; Yoshida, Y1
Cercek, A; Kemeny, NE; Park, V; Reidy-Lagunes, D; Saltz, LB; Segal, NH; Stadler, ZK; Varghese, A; Yaeger, R1
An, X; Feng, F; He, YJ; Li, YH; Wang, FH; Wang, ZQ; Xiang, XJ; Xu, RH; Zhao, Y1
Aguilella-Vizcaíno, MJ; Calleja-Hernández, MÁ; Cortés-Funes Castro, H; Cortijo-Cascajares, S; García-Escobar, I; Herreros-de-Tejada, A; Nacle-López, I1
Liu, CY1
Fung, A; Viale, PH; Zitella, L1

Reviews

1 review(s) available for capecitabine and Allergy, Drug

ArticleYear
Advanced colorectal cancer: current treatment and nursing management with economic considerations.
    Clinical journal of oncology nursing, 2005, Volume: 9, Issue:5

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Camptothecin; Capecitabine; Cause of Death; Colorectal Neoplasms; Deoxycytidine; Diarrhea; Drug Costs; Drug Hypersensitivity; Drug Industry; Female; Fluorouracil; Humans; Irinotecan; Male; Medical Assistance; Nausea; Neoplasm Staging; Nurse's Role; Oncology Nursing; Organoplatinum Compounds; Oxaliplatin; Paresthesia; Patient Education as Topic; Treatment Outcome; United States; Vomiting

2005

Trials

1 trial(s) available for capecitabine and Allergy, Drug

ArticleYear
A single-arm Phase II validation study of preventing oxaliplatin-induced hypersensitivity reactions by dexamethasone: the AVOID trial.
    Drug design, development and therapy, 2015, Volume: 9

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Bevacizumab; Capecitabine; Colorectal Neoplasms; Dexamethasone; Drug Combinations; Drug Hypersensitivity; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Prospective Studies

2015

Other Studies

6 other study(ies) available for capecitabine and Allergy, Drug

ArticleYear
Comparison between hypersensitivity reactions to cycles of modified FOLFOX6 and XELOX therapies in patients with colorectal cancer.
    Cancer chemotherapy and pharmacology, 2017, Volume: 79, Issue:5

    Topics: Aged; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colorectal Neoplasms; Combined Modality Therapy; Deoxycytidine; Dexamethasone; Drug Hypersensitivity; Female; Fluorouracil; Humans; Incidence; Leucovorin; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Oxaloacetates; Retrospective Studies; Risk Factors

2017
[A Case of Postoperative Recurrence of Rectal Cancer in Which Desensitization Therapy Was Effective against Oxaliplatin Allergy in L-OHP].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2018, Volume: 45, Issue:5

    Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Combined Modality Therapy; Desensitization, Immunologic; Drug Hypersensitivity; Humans; Male; Organoplatinum Compounds; Oxaliplatin; Rectal Neoplasms; Recurrence

2018
Faster FOLFOX: Oxaliplatin Can Be Safely Infused at a Rate of 1 mg/m2/min.
    Journal of oncology practice, 2016, Volume: 12, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Drug Administration Schedule; Drug Hypersensitivity; Fluorouracil; Humans; Leucovorin; Organoplatinum Compounds

2016
[Clinical features of hypersensitivity reactions to oxaliplatin among Chinese colorectal cancer patients].
    Chinese journal of cancer, 2010, Volume: 29, Issue:1

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adolescent; Adult; Aged; Anaphylaxis; Anti-Allergic Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asian People; Capecitabine; Child; Colorectal Neoplasms; Deoxycytidine; Drug Hypersensitivity; Female; Fluorouracil; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Oxaloacetates; Retrospective Studies; Sex Factors; Young Adult

2010
Effectiveness of oxaliplatin desensitization protocols.
    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2013, Volume: 15, Issue:3

    Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Colorectal Neoplasms; Deoxycytidine; Desensitization, Immunologic; Drug Hypersensitivity; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Metastasis; Organoplatinum Compounds; Oxaliplatin; Prognosis; Retrospective Studies; Skin Tests

2013
Fluorouracil for allergic reactions to capecitabine.
    The Annals of pharmacotherapy, 2002, Volume: 36, Issue:12

    Topics: Adult; Antineoplastic Agents; Breast Neoplasms; Capecitabine; Deoxycytidine; Drug Hypersensitivity; Female; Fluorouracil; Humans; Salvage Therapy

2002